Hydroxychloroquine – New Evidence for Better Pregnancy Outcomes in APS
Aya Berman, Family medicine resident at Clalit Health Services, shared a post on LinkedIn:
“Thrilled to share our new study: ‘Hydroxychloroquine and pregnancy outcomes in patients with anti-phospholipid syndrome: a systematic review and meta-analysis” is now published in RMD Open.
This study represents a meaningful step in understanding the role of hydroxychloroquine in improving obstetric outcomes for patients with antiphospholipid syndrome.
The findings were first presented by Dr. Orly Efros at the International Society on Thrombosis and Haemostasis (ISTH) Annual Congress in Bangkok, and I am delighted that the full manuscript is now available here.
Grateful to my colleagues and collaborators for their dedication and contributions that made this work possible!
Orly Efros, Gili Kenet, Aharon lubetsky, Nancy Agmon-Levin, Shelly Soffer, MD, assaf barg, Sarina Levy mendelovich, omri cohen, Liat Waldman Radinsky, Shadan Lalezari, Eyal Klang”

Stay updated with Hemostasis Today.
-
Aug 26, 2026, 22:59Debbe McCall: Should Frail Elderly Patients Stable on Warfarin Switch to DOACs?
-
Aug 26, 2026, 18:38Maia Meier: Muhiba’s Story of Courage, Resilience and Hope With Type 3 VWD
-
Aug 26, 2026, 18:27Isabella Presch: Not Every Genome-Editing Program Needs to Start From Zero
-
Aug 26, 2026, 18:24New Educational Content for the Bleeding Disorders Community – EAHAD
-
Aug 26, 2026, 18:14N. Mariana S. Vasquez: From Skin and Gut to Celiac Disease
-
Aug 26, 2026, 18:13Francesca Granata: What Happens When Patients Become Researchers and Researchers Become Advocates?
-
Aug 26, 2026, 18:11Maxima Mendez: Statins Are No Longer the Whole Story
-
Aug 26, 2026, 18:06Ashkan Shoamanesh: ANNEXa-I Analyses Inform Individualized Treatment in Intracranial Hemorrhage
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation